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Republic  of  Korea)  were  placed,  resulting  in  signiﬁcant
reduction  in  the  size  of  the  endobiliary  tumor  mass  (ﬁg.  1D).
Clinical  and  ultrasound  follow-up  at  4  months  revealed  no
complications.n  82-year-old  man  that  had  hilar  biliary  obstruction
ith  right  percutaneous  internal-external  biliary  drainage
ﬁg.  1A)  underwent  transluminal  biliary  forceps  biopsy  at
he  level  of  the  hepatic  hilum,  resulting  in  iatrogenic  injury
a  small  tear  with  a  leak)  to  the  bile  duct  with  conse-
uent  intrahepatic  collection  (ﬁg.  1B).  The  biopsy  revealed
alignant  hilar  cholangiocarcinoma,  making  the  patient  a
andidate  for  palliative  care.  He  underwent  percutaneous
ndobiliary  bipolar  radiofrequency  (Habib® EndoHPB;  EMci-
ion,  London,  UK)  (ﬁg.  1C)  for:  a)  cauterizing  the  bile  duct
njury  with  the  persistent  intrahepatic  collection,  and  b)
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nd  consequent  tumor  growth  delay.  In  the  same  operating
ession,  the  bile  duct  lesion  was  treated  with  endobil-
ary  radiofrequency  and  self-expandable  bare  metal  stents
ith  a  T-conﬁguration  (10  x  80  mm  Zilver®  Biliary  Self-
xpanding  Stent,  Cook  Medical,  Bloomington,  IN,  USA;  and
0  x  100  mm  LCD® Biliary  Stent,  Taewoong  Medical  Co., by Masson Doyma Me´xico S.A. This is an open access article under
d/4.0/).
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Figure  1  A)  Cholangiography  showing  the  right  percutaneous  internal-external  biliary  drainage,  positioned  for  a  suspected  malig-
nant hilar  biliary  obstruction.  B)  Cholangiography  after  transluminal  biliary  forceps  biopsy  at  the  level  of  the  hepatic  hilum  that
shows the  iatrogenic  injury  to  the  bile  duct  with  an  intrahepatic  collection.  C)  Radiologic  control  during  percutaneous  endobiliary
bipolar radiofrequency  at  the  level  of  the  hepatic  hilum.  D)  Final  cholangiography  showing  improvement  of  the  bile  duct  lesion,
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Conﬂict of interestgood expansion  of  the  self-expandable  bare  metal  stents  with  a
biliary system  into  the  duodenum.
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